These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 18332466

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.
    Girinsky T, Lapusan S, Ribrag V, Koscielny S, Ferme C, Carde P.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):476-9. PubMed ID: 15667970
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma.
    Emmanouilides C, Asuncion DJ, Wolf C, Scott S, Territo M.
    Bone Marrow Transplant; 2003 Nov 01; 32(9):863-7. PubMed ID: 14561985
    [Abstract] [Full Text] [Related]

  • 28. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
    Martín A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, Andreu R, Salar A, García-Sanchez P, Vázquez L, Nistal S, Requena MJ, Donato EM, González JA, León A, Ruiz C, Grande C, González-Barca E, Caballero MD, Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Cooperative Group).
    Haematologica; 2008 Dec 01; 93(12):1829-36. PubMed ID: 18945747
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
    Modak S, Gardner S, Dunkel IJ, Balmaceda C, Rosenblum MK, Miller DC, Halpern S, Finlay JL.
    J Clin Oncol; 2004 May 15; 22(10):1934-43. PubMed ID: 15143087
    [Abstract] [Full Text] [Related]

  • 32. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience.
    Mazzarotto R, Boso C, Vianello F, Aversa MS, Chiarion-Sileni V, Trentin L, Zambello R, Muzzio PC, Fiore D, Sotti G.
    Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):823-9. PubMed ID: 17379431
    [Abstract] [Full Text] [Related]

  • 33. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
    Rosenbluth BD, Yahalom J.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1185-91. PubMed ID: 16682133
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
    Laskar S, Bahl G, Muckaden MA, Nair R, Gupta S, Bakshi A, Gujral S, Shet T, Shrivastava SK, Dinshaw KA.
    Cancer; 2007 Aug 15; 110(4):816-23. PubMed ID: 17582622
    [Abstract] [Full Text] [Related]

  • 36. [Treatment outcomes and prognostic analyses of relapsed or refractory T-cell non-Hodgkin's lymphoma].
    Gao Y, Huang HQ, Lin XB, Cai QQ, Pan ZH, Wang BF, Bu Q.
    Ai Zheng; 2007 Aug 15; 26(8):909-13. PubMed ID: 17697558
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation.
    Tsai D, Moore H, Hardy C, Porter D, Loh E, Vaughn D, Luger S, Schuster S, Stadtmauer E.
    Bone Marrow Transplant; 1999 Sep 15; 24(5):521-6. PubMed ID: 10482937
    [Abstract] [Full Text] [Related]

  • 39. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
    Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S.
    Biol Blood Marrow Transplant; 2005 Nov 15; 11(11):903-11. PubMed ID: 16275593
    [Abstract] [Full Text] [Related]

  • 40. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
    Mundt AJ, Sibley G, Williams S, Hallahan D, Nautiyal J, Weichselbaum RR.
    Int J Radiat Oncol Biol Phys; 1995 Sep 30; 33(2):261-70. PubMed ID: 7673013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.